SCHEMBL599374

SCHEMBL599374

c1cnc2c(c1)ccc1ccc(-c3ccc(-c4ccc5ccc6cccnc6c5n4)cc3)nc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.67
CCR1 P32246 3/20 0.67
CCR5 P51681 3/20 0.67
CCR8 P51685 3/20 0.67
MMP2 P08253 2/20 0.67
TSHR P16473 2/20 0.67
CYP3A4 P08684 2/20 0.67
CYP2D6 P10635 2/20 0.67
KDM4E B2RXH2 2/20 0.67
MAPT P10636 2/20 0.67
HTT P42858 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
GMNN O75496 1/20 0.67
TP53 P04637 1/20 0.67
HSP90AA1 P07900 1/20 0.67
MMP9 P14780 1/20 0.67
ALOX15 P16050 1/20 0.67
NFKB1 P19838 1/20 0.67
MMP8 P22894 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10032468 0.98 LMNA (0.64) LMNACCR1CCR5CCR8MMP2
SCHEMBL29888960 0.98 LMNA (0.64) LMNACCR1CCR5CCR8MMP2
SCHEMBL30837267 0.94 LMNA (0.59) LMNACCR1CCR5CCR8MMP2
SCHEMBL29192757 0.94 LMNA (0.59) LMNACCR1CCR5CCR8MMP2
SCHEMBL17174057 0.93 KDM4E (0.57) LMNACCR1CCR5CCR8MMP2
SCHEMBL20726724 0.93 LMNA (0.57) LMNACCR1CCR5CCR8MMP2
SCHEMBL17174041 0.93 LMNA (0.57) LMNACCR1CCR5CCR8MMP2
SCHEMBL1395123 0.92 LMNA (0.61) LMNACCR1CCR5CCR8MMP2
SCHEMBL30449837 0.92 LMNA (0.61) LMNACCR1CCR5CCR8MMP2
SCHEMBL19768558 0.91 CCR1 (0.55) LMNACCR1CCR5CCR8MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025081143-A1 RADIOLUMINESCENT EYE DEVICE FOR MODULATION OF PHOTORECEPTOR METABOLISM City Labs, Inc. (US) 2025-04-17 WO claimed
CN-115666148-A CsPbI 3 Optimization method of red light perovskite nanocrystalline LED device 吉林大学 2023-01-31 CN claimed
US-11434312-B2 Photocurable composition for forming cured layers with high thermal stability CANON KABUSHIKI KAISHA (JP) 2022-09-06 US claimed
WO-2022132356-A1 PHOTOCURABLE COMPOSITION FOR FORMING CURED LAYERS WITH HIGH THERMAL STABILITY CANON KABUSHIKI KAISHA (JP) 2022-06-23 WO claimed
US-20220185914-A1 PHOTOCURABLE COMPOSITION FOR FORMING CURED LAYERS WITH HIGH THERMAL STABILITY CANON KABUSHIKI KAISHA (JP) 2022-06-16 US claimed
CN-122011477-A Functionalized diaphragm, preparation method thereof and lithium ion battery 安徽得壹能源科技有限公司 2026-05-12 CN disclosed
US-20260118301-A1 SENSOR FOR MEASURING A GAS PROPERTY INFINEON TECHNOLOGIES AG (DE) 2026-04-30 US disclosed
EP-3474042-B1 PLASTIC SCINTILLATION FIBER AND MANUFACTURING METHOD FOR SAME KURARAY CO (JP) 2026-03-25 EP disclosed
EP-4709801-A1 ARCHITECTURAL COATING COMPOSITION Rohm and Haas Company (US) 2026-03-18 EP disclosed
US-12545650-B2 Bisanthracene derivatives having solubilizing substituent, and organic electroluminescence device using same LG CHEM, LTD. (KR) 2026-02-10 US disclosed
US-12391866-B2 Surfactant mixtures for enhanced oil recovery SAUDI ARABIAN OIL COMPANY (SA) 2025-08-19 US disclosed
US-20250257226-A1 ROOF COATING RESISTANT TO BIOFOULING DOW GLOBAL TECHNOLOGIES LLC (US) 2025-08-14 US disclosed
WO-2007127069-A1 ELECTROLUMINESCENT DEVICE INCLUDING AN ANTHRACENE DERIVATIVE EASTMAN KODAK COMPANY (US) 2007-11-08 WO disclosed
US-20070252522-A1 Electroluminescent device including an anthracene derivative EASTMAN KODAK COMPANY 2007-11-01 US disclosed
US-20070252522-A1 Electroluminescent device including an anthracene derivative EASTMAN KODAK COMPANY 2007-11-01 US disclosed
US-20070252521-A1 Electroluminescent device including an anthracene derivative EASTMAN KODAK COMPANY 2007-11-01 US disclosed
US-20070252521-A1 Electroluminescent device including an anthracene derivative EASTMAN KODAK COMPANY 2007-11-01 US disclosed
EP-1783189-A1 MATERIAL FOR LUMINESCENT ELEMENT AND LUMINESCENT ELEMENT TORAY INDUSTRIES, INC. (JP) 2007-05-09 EP disclosed
US-20070044829-A1 Photoelectric conversion layer, photoelectric conversion device and imaging device, and method for applying electric field thereto FUJI PHOTO FILM CO., LTD. 2007-03-01 US disclosed
US-20070044829-A1 Photoelectric conversion layer, photoelectric conversion device and imaging device, and method for applying electric field thereto FUJI PHOTO FILM CO., LTD. 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545650-B2 Bisanthracene derivatives having solubilizing substituent, and organic electroluminescence device using same NCOR2, NCOR1, ESR2 LMNA 2160/4885CCR1 1038/4885CCR5 2237/4885
US-20260118301-A1 SENSOR FOR MEASURING A GAS PROPERTY GSDMD, TRPA1, GPR139 LMNA 3675/4885CCR1 1861/4885CCR5 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.